Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Hum Vaccin Immunother ; 17(1): 224-227, 2021 01 02.
Artículo en Inglés | MEDLINE | ID: mdl-32530771

RESUMEN

We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully. One patient was confirmed to have vaccine-associated rubella via sequencing of virus isolated in viral culture. The other patient had a pharyngeal swab positive for rubella virus PCR, with sequencing matching the vaccine strain. There are few reports of clinical disease from rubella vaccine-strains in the literature. Previous authors have reported severe disseminated vaccine-associated rubella in both immunodeficient and immunocompetent patients. Further study is required to ascertain the incidence, risk factors, and clinical characteristics of this condition; as well as investigate the extent of horizontal transmission to guide infection control recommendations.


Asunto(s)
Sarampión , Paperas , Rubéola (Sarampión Alemán) , Adulto , Anticuerpos Antivirales , Humanos , Lactante , Vacuna contra el Sarampión-Parotiditis-Rubéola/efectos adversos , Rubéola (Sarampión Alemán)/prevención & control , Vacuna contra la Rubéola/efectos adversos , Vacunación
3.
Ann Acad Med Singap ; 39(9): 705-9, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20957306

RESUMEN

INTRODUCTION: IgA nephropathy is a disease where the pathogenesis is still poorly understood. Deoxyribonucleic acid (DNA) microarray technique allows tens of thousands of gene expressions to be examined at the same time. Commercial availability of microarray genechips has made this powerful tool accessible for wider utilisation in the study of diseases. MATERIALS AND METHODS: Seven patients with IgA nephropathy, 6 with minimal change nephrotic syndrome (MCNS) as patient controls and 7 normal healthy subjects were screened for the differential expression of genes, genome-wide. The Human Genome U133 Plus 2.0 Arrays (Affymetrix, USA) were used to quantitate the differential expression of 38,500 well-characterised human genes. RESULTS: A total of 7761 gene expressions were identified that have an IgAN/Normal gene expression ratio of 0.06-fold to 5.58-fold. About 35% of the altered gene expressions have no gene title or just a hypothetical protein label such as FLJ30679. Most of the remaining 65% are identified proteins where their importance to IgAN is not immediately apparent at this time. Among the 30 most upregulated and 30 most downregulated genes are Urotensin 2 (upregulated 3.09-fold, P <0.05) and Fatty-acid binding protein 6 (downregulated to 0.12-fold, P <0.05). Retinoic acid receptor alpha (vitamin A receptor) was also found downregulated to 0.41-fold (P <0.005). Taqman realtime polymerase chain reaction (PCR) for urotensin 2 and retinoic acid receptor alpha (RARA) were performed on 20 patients with IgA nephropathy and 11 with Minimal Change Disease and the data correlated with various clinical indices. CONCLUSIONS: The findings suggest that there may be a therapeutic role for retinoic acid receptor alpha (RARA) in IgA nephropathy and a clinical monitoring role for Urotensin 2 in Minimal Change Disease.


Asunto(s)
Expresión Génica , Glomerulonefritis por IGA/genética , Inmunoglobulina A/genética , Nefrosis Lipoidea/genética , Receptores Acoplados a Proteínas G/genética , Receptores de Ácido Retinoico/genética , Tretinoina/metabolismo , Adulto , Anciano , Estudios de Casos y Controles , Femenino , Regulación de la Expresión Génica , Estudio de Asociación del Genoma Completo , Glomerulonefritis por IGA/metabolismo , Glomerulonefritis por IGA/patología , Humanos , Inmunoglobulina A/metabolismo , Masculino , Persona de Mediana Edad , Nefrosis Lipoidea/metabolismo , Nefrosis Lipoidea/patología , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa , Receptores Acoplados a Proteínas G/metabolismo , Receptores de Ácido Retinoico/metabolismo
5.
Mov Disord ; 21(10): 1765-8, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16941465

RESUMEN

A recent meta-analysis observed a greater significant inverse association of the ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y variant with Parkinson's disease (PD) for Asian (predominantly Japanese) populations compared with Caucasian populations. We performed an independent case-control study in 335 PD and 341 control subjects with data from a Chinese population to investigate the age-of-onset effect of the UCHL1 variant in PD. The Y/Y and Y/S genotypes were less frequent in the PD young-onset group than in controls and the frequency of the Y alleles was higher in young controls compared to young-onset PD (age at examination

Asunto(s)
Variación Genética/genética , Genotipo , Enfermedad de Parkinson/genética , Ubiquitina Tiolesterasa/genética , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Genético/genética , Valores de Referencia , Singapur
6.
Mov Disord ; 21(6): 789-93, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16482571

RESUMEN

Pathogenic PINK1 mutations have been described in PARK6-linked Parkinson's disease (PD) patients of Asian origin. However, data on the frequency of PINK1 mutations in sporadic early-onset Parkinson's disease (EOPD) Asian patients are lacking. The objectives of this study were to report the frequency of PINK1 mutations of sporadic EOPD in an Asian cohort comprising of ethnic Chinese, Malays, and Indians, and to highlight a PINK1-positive patient who presented with restless legs symptoms. Eighty consecutive sporadic EOPD patients from the movement disorder clinics of two major tertiary institutions in the country were included. We performed sequence analysis of all the coding and exon-intron junctions of the PINK1 using specific primer sets. In addition, we genotyped polymorphisms detected from the analysis in a group of sporadic PD patients and controls. Three different mutations (two homozygous nonsense and one heterozygous missense) in the putative kinase domain were found in three patients, giving a 3.7% frequency of PINK1 mutations in our EOPD cohort. All the mutations were absent in 200 healthy controls. One patient with a novel homozygous nonsense PINK1 mutation presented unusually with restless legs symptoms. Separately, analysis of the frequency of four PINK1 polymorphisms in a group of sporadic PD and controls did not reveal any significant differences. We highlight a 3.7% frequency of PINK1 mutations in an Asian cohort (ethnic Chinese, Malay, and Indian) of EOPD. The phenotypic spectrum associated with PINK1-positive patients may be wider than previously reported. Polymorphisms of PINK1 do not appear to modulate risk of PD in our population.


Asunto(s)
Pueblo Asiatico/genética , Mutación , Enfermedad de Parkinson/genética , Proteínas Quinasas/genética , Adulto , Edad de Inicio , Secuencia de Bases , Cartilla de ADN , Etnicidad , Tamización de Portadores Genéticos , Homocigoto , Humanos , Persona de Mediana Edad , Singapur
7.
J Med Microbiol ; 52(Pt 10): 925-930, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12972590

RESUMEN

Competition, competitive exclusion and displacement of eight strains of Escherichia coli and Salmonella spp. by Lactobacillus rhamnosus GG and Lactobacillus casei Shirota from adhesion on human intestinal mucus glycoproteins and Caco-2 cell surfaces were studied. Lactobacilli were able to compete with, exclude and displace pathogenic gastrointestinal (GI) bacteria when they were incubated together, but the degree of inhibition of adhesion was bacterial strain-dependent. Competition and exclusion profiles of GI bacteria by lactobacilli were similar. Displacement profiles of GI bacteria were different from those of competition and exclusion and the process was relatively slow: displacement equilibrium took more than 2 h. These findings are important for development, selection and in vitro assessment of target- and function-specific probiotics.


Asunto(s)
Escherichia coli/fisiología , Enfermedades Intestinales/microbiología , Mucosa Intestinal/microbiología , Lactobacillus/fisiología , Salmonella/fisiología , Adhesión Bacteriana/fisiología , Células CACO-2 , Infecciones por Escherichia coli/microbiología , Glicoproteínas/fisiología , Humanos , Mucosa Intestinal/fisiología , Probióticos , Infecciones por Salmonella/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...